$210 Million is the total value of Cabot-Wellington, LLC's 17 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IVV | iShares Core S&P | $1,328,000 | +6.0% | 3,337 | 0.0% | 0.63% | -0.6% | |
HON | Honeywell Intl Inc | $421,000 | +1.9% | 1,940 | 0.0% | 0.20% | -4.3% | |
FDX | Fedex Corp Com | $370,000 | +9.5% | 1,300 | 0.0% | 0.18% | +2.3% | |
PFE | Pfizer | $332,000 | -1.5% | 9,150 | 0.0% | 0.16% | -7.6% | |
MMM | 3M | $260,000 | +10.2% | 1,350 | 0.0% | 0.12% | +3.3% | |
IJH | iShares Core S&P | $98,000 | +12.6% | 377 | 0.0% | 0.05% | +6.8% | |
GILD | Gilead Sciences Inc | $76,000 | +11.8% | 1,175 | 0.0% | 0.04% | +2.9% | |
VWO | Vanguard Intl Equity (index Fund Inc FTSE Emerging Markets Etf) | $27,000 | +3.8% | 515 | 0.0% | 0.01% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-12-30
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
JOHNSON &JOHNSON | 38 | Q3 2022 | 0.5% |
Cabot Corp Com | 37 | Q2 2022 | 16.6% |
PFIZER INC | 37 | Q2 2022 | 0.3% |
COTERRA ENERGY INC | 35 | Q4 2021 | 20.7% |
HONEYWELL INTL INC | 35 | Q4 2021 | 0.3% |
VANGUARD TOTL SM ETF | 34 | Q2 2024 | 75.7% |
3M COMPANY | 34 | Q3 2021 | 0.3% |
Fedex Corp Com | 34 | Q4 2021 | 0.2% |
iShares Trust Core | 32 | Q2 2024 | 38.8% |
GILEAD SCIENCES INC | 23 | Q3 2021 | 10.5% |
View Cabot-Wellington, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-28 |
13F-HR | 2024-07-25 |
13F-HR | 2024-05-23 |
13F-HR | 2024-02-08 |
13F-HR | 2023-11-07 |
13F-HR | 2023-07-26 |
13F-HR | 2023-05-15 |
13F-HR | 2023-03-21 |
13F-HR | 2023-03-21 |
13F-HR | 2023-03-21 |
View Cabot-Wellington, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.